about
Does central sensitization help explain idiopathic overactive bladder?An update on the use of transdermal oxybutynin in the management of overactive bladder disorderOnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical TrialThe female urinary microbiome: a comparison of women with and without urgency urinary incontinence.Acupuncture for adults with overactive bladder: a systematic review protocol.Validation of a self-administered instrument to measure adherence to anticholinergic drugs in women with overactive bladder.Incontinence medication response relates to the female urinary microbiota.Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) TrialAnticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.The Burden of Overactive Bladder on US Public HealthWhat predicts and what mediates the response of urge urinary incontinence to biofeedback?Cycling Versus Continuous Mode In Neuromodulator Programming: A Crossover, Randomized, Controlled Trial.Female urinary incontinence and sexuality.The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial.Quantitative Changes in Cerebral Perfusion during Urinary Urgency in Women with Overactive Bladder.Acupuncture for adults with overactive bladder: A systematic review and meta-analysis of randomized controlled trials.Recalcitrant chronic bladder pain and recurrent cystitis but negative urinalysis: What should we do?
P2860
Q26744440-D6A0236C-247B-4A8F-B3D1-A232FB20F934Q26749105-B1BE4D45-24AB-4BF6-8ADC-5EC2E09382A6Q33587587-6E866C89-F970-44C7-B7AD-75F02D642150Q34165475-113EB6C3-E8C5-4EE5-B1DD-4A4875E5C06EQ34903525-07BA2DC1-2BF5-43E1-BB47-038D1B68AFCEQ35572326-4EEB84D1-1FE4-4723-8F7F-B8AE9128116CQ35794040-5B21A3E0-1530-4296-AE66-303180B60D93Q36223634-DF74E8B7-37FF-4EFD-9EFA-61D9515B2C01Q36386201-E105CB04-4731-4F4B-9213-395FF01604B5Q36528534-C9347A4E-7660-4759-AFB1-F68F2ACCC517Q36767014-BBBFECCB-833A-43F0-8DA2-C8E8B5C686B2Q36851485-F3A6563E-9CE3-4EE8-8980-45BBDB46646FQ37595859-A7B67C9B-48BE-4A4C-B2D0-AC6096D1AA28Q37626489-C5A530A0-AF03-45A8-86DE-B5B75626E4EAQ37707864-20530558-CD6C-4146-9121-551A24F294C9Q41622683-F7B87A7A-C218-4EF3-BDC5-7036667661D4Q49712145-74493244-862A-4F29-AD3B-7D4C8694EFC3Q51738072-A4080062-8029-4C59-A682-3DC5FE60CDE7
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment of overactive bladder in women.
@ast
Treatment of overactive bladder in women.
@en
type
label
Treatment of overactive bladder in women.
@ast
Treatment of overactive bladder in women.
@en
prefLabel
Treatment of overactive bladder in women.
@ast
Treatment of overactive bladder in women.
@en
P2093
P1476
Treatment of overactive bladder in women
@en
P2093
Danie H Biller
J Nikki McKoy
Jeffrey D Blume
Katherine E Hartmann
Laura Meints
Melissa L McPheeters
Rebecca N Jerome
Renée M Ward
Sandra R Micucci
Theresa A Scott
P304
P577
2009-08-01T00:00:00Z